Purple Book reference family · 351(a) biologic
Typhoid Vi Polysaccharide Vaccine (Typhim Vi)
Typhoid Vi Polysaccharide Vaccine is an FDA-licensed reference biologic from Sanofi Winthrop Industrie.
351(a) biologicBLA 103936 Sanofi Winthrop Industrie
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
2000
Reference product
Originator biologic
351(a)BLA 103936
Typhim Vi Typhoid Vi Polysaccharide Vaccine
Sanofi Winthrop Industrie
View full reference-product record- Approved
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Protection horizon
Reference approval
Approval date of the reference Typhoid Vi Polysaccharide Vaccine product.
26 yr 10 mo ago
Typhoid Vi Polysaccharide Vaccine: frequently asked questions
Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.
Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for Typhoid Vi Polysaccharide Vaccine.
Related FDA reference tools
- FDA Orange BookApproved drugs, generics, therapeutic-equivalence codes, patents, and exclusivity.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
